Infliximab 100mg powder for solution for infusion vials
NHS hospitals in England used £380,573,832 of indicative cost of Infliximab 100mg powder for solution for infusion vials in the 12 months to April 2026, about 1.5% of all hospital medicines spend. That is up 3.8% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Infliximab 100mg powder for solution for infusion vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Infliximab 100mg powder for solution for infusion vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £13,853,098 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £13,787,957 |
| Manchester University Nhs Ft | £11,624,241 |
| Guy's & St Thomas' Nhs Foundation Trust | £8,991,284 |
| University Hpls Of Leicester Nhs Trust | £8,266,421 |
| Cambridge Univ Hosp Nhs Foundation Trust | £7,706,244 |
| Oxford University Hospitals Nhs Ft | £7,696,773 |
| Sheffield Teaching Hospitals Nhs Trust | £7,692,999 |
| Western Sussex Hospitals Nhs Found Trust | £7,652,680 |
| Hampshire Hospitals Nhs Foundation Trust | £7,363,276 |
The primary-care picture
Infliximab is also dispensed in the community. See the national primary-care prescribing volume, cost and trend on the Infliximab medicine page.